DLSS 5 comes with a massive 50-60% performance hit, so I hope you like lower frame rates with your dose of AI image enhancement

A comparison of the appearance of a game character using three different DLSS 5 AI models
(Image credit: Nvidia)

I walked into Nvidia's DLSS 5 demo last week with some preconceptions, I'll be honest. I hadn't enjoyed the images it had produced to date, and I was sceptical about the benefits it could bring to our beloved games. Not to mention the troubling notion of AI-altered images entering into our hobby, even if you can turn them off with a simple checkbox.

Marvel Dimensions: How Legendary Artist Alex Ross Is Returning to Paint an Epic New Chapter in Marvel Comics History

Jesse Schedeen Avatar

Posted

: Sep 1, 2026 1:00pm UTC

As the artist behind monumental epics like Marvels and Kingdom Come, it goes without saying that Alex Ross is a huge name in the world of comics. In the wake of 2022's Fantastic Four: Full Circle, we're excited to see Ross crafting another original graphic at Abrams ComicArts, this time dubbed Marvel Dimensions.

Mindfulness may lower blood pressure in just 8 weeks

Simple practices such as mindfulness, gratitude journaling, and optimism training may improve several markers of cardiovascular health within a matter of weeks. A recent study found that these positive psychology interventions were consistently associated with improvements in blood pressure, inflammation, and other heart disease risk factors. Because some of the benefits appeared to be connected with healthier behaviors, including better eating habits and increased physical activity, the researchers said continued reinforcement may be necessary to maintain progress over time.

All the RPS Supporter rewards for August 2026: fatty felines, GTA 6 pondering, and a heap of barely washed radishes

It’s been an unusual month

Image credit: Rock Paper Shotgun

You there. Have you completed the RPS Supporters survey? You don’t even need to be a Supporter. In fact, it’s better for certain questions if you aren’t. Either way, this is your chance to play a part in making sure our subscription rewards are as rewarding as rewards can be, which some might say is a reward in itself.

Global bond yields soar to multi-decade highs as Middle East turmoil reignites inflation fears

Government bond yields jumped across major markets Tuesday, with borrowing costs in Japan and the U.K. touching multi-decade highs, and U.S. Treasury yields surging, as renewed Middle East hostilities reignite inflation concerns.

At $4,700, Could You Overlook This Exquisite 2000 Volvo V70 XC's One Major Flaw? - Jalopnik

Despite looking like it deserves a place in Volvo's Gothenburg Museum, today's Nice Price or No Dice V70 XC hides a heart-wrenching secret: it has a rebuilt title. Would that impact your interest in its price despite its otherwise phenomenal presentation?

Reaching 90 without dementia doesn’t mean you’re in the clear

People who reach their 90s without dementia might appear to have escaped much of the danger of cognitive decline. Until recently, however, scientists had relatively little evidence showing what happens to dementia risk at such advanced ages.

Trump suggests he is reviewing US support for UK over Falkland Islands

Donald Trump has suggested he is reconsidering US support for Britain’s sovereignty over the Falkland Islands, in a move likely to strain the “special relationship” between Washington and London.

“I always review every position – that’s just one of many,” the US president told reporters in the White House, in response to a question about whether he was reviewing the US’s position over the South Atlantic islands, an archipelago whose status has long been disputed by Argentina, which claims sovereignty.

NASA’s Swift telescope is back, but time is running out

NASA's Neil Gehrels Swift Observatory is back to studying the universe with two of its three science instruments after plans to raise the spacecraft into a higher orbit were scaled back.

Goodbye CPAP? New sleep apnea pill cuts breathing events by 44%

A once-nightly oral medication significantly improved obstructive sleep apnea in a large phase 3 clinical trial presented at the 2026 ATS International Conference. The drug, known as AD109, is designed to treat OSA by targeting the neuromuscular problems that contribute to airway collapse during sleep.